Drugs / CWP-0403
last change Apr 2010 re-read 3 minutes ago

CWP-0403

Developed for
type 2 diabetes mellitus
Investigated by
JW Pharmaceutical

Trials 1

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00888719 Feb 2009 → Jan 2010 type 2 diabetes mellitus JW Pharmaceutical Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CWP-0403 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00888719 ↗